Banner image
HealthQuad

India’s leading healthcare focused venture & growth capital fund.

Included in the AvH investment portfolio since 2017
(Fund I) and 2020 (Fund II).

36.27 %

Beneficial interest AvH

Fund I

10.98 %

Beneficial interest AvH

Fund II

Press releases - Growth capital 

View All
Growth Capital

Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG

Growth Capital

Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands

Growth Capital

Mediahuis België presents transformation plan to strengthen the organisation for the future